Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm

Personalized medicine: Signature-guided cancer therapy Personalized cancer therapy is one of the holy grails of oncology, as the ability to determine what treatment would best benefit a patient would serve not only to improve outcomes, but also mitigate side effects from less effective treatments. H...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel J. McGrail, Curtis Chun-Jen Lin, Jeannine Garnett, Qingxin Liu, Wei Mo, Hui Dai, Yiling Lu, Qinghua Yu, Zhenlin Ju, Jun Yin, Christopher P. Vellano, Bryan Hennessy, Gordon B. Mills, Shiaw-Yih Lin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Acceso en línea:https://doaj.org/article/b2d7262023a5464f9e1788ca4d9c8cbf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b2d7262023a5464f9e1788ca4d9c8cbf
record_format dspace
spelling oai:doaj.org-article:b2d7262023a5464f9e1788ca4d9c8cbf2021-12-02T11:41:50ZImproved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm10.1038/s41540-017-0011-62056-7189https://doaj.org/article/b2d7262023a5464f9e1788ca4d9c8cbf2017-03-01T00:00:00Zhttps://doi.org/10.1038/s41540-017-0011-6https://doaj.org/toc/2056-7189Personalized medicine: Signature-guided cancer therapy Personalized cancer therapy is one of the holy grails of oncology, as the ability to determine what treatment would best benefit a patient would serve not only to improve outcomes, but also mitigate side effects from less effective treatments. Here, we develop algorithms to predict what patients will respond to a given therapeutic modality, as well as ways to specifically target any observed phenotype, by integrating large scale data sets that profile cancer cell line gene expression and sensitivity to hundreds of drugs. Furthermore, we show how these gene expression signatures can be used to predict novel synergizing agents to further enhance the efficacy of these therapeutics. Taken together, this work stands to advance the era of personalized medicine by enabling precision medicine approaches in the clinic.Daniel J. McGrailCurtis Chun-Jen LinJeannine GarnettQingxin LiuWei MoHui DaiYiling LuQinghua YuZhenlin JuJun YinChristopher P. VellanoBryan HennessyGordon B. MillsShiaw-Yih LinNature PortfolioarticleBiology (General)QH301-705.5ENnpj Systems Biology and Applications, Vol 3, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Daniel J. McGrail
Curtis Chun-Jen Lin
Jeannine Garnett
Qingxin Liu
Wei Mo
Hui Dai
Yiling Lu
Qinghua Yu
Zhenlin Ju
Jun Yin
Christopher P. Vellano
Bryan Hennessy
Gordon B. Mills
Shiaw-Yih Lin
Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
description Personalized medicine: Signature-guided cancer therapy Personalized cancer therapy is one of the holy grails of oncology, as the ability to determine what treatment would best benefit a patient would serve not only to improve outcomes, but also mitigate side effects from less effective treatments. Here, we develop algorithms to predict what patients will respond to a given therapeutic modality, as well as ways to specifically target any observed phenotype, by integrating large scale data sets that profile cancer cell line gene expression and sensitivity to hundreds of drugs. Furthermore, we show how these gene expression signatures can be used to predict novel synergizing agents to further enhance the efficacy of these therapeutics. Taken together, this work stands to advance the era of personalized medicine by enabling precision medicine approaches in the clinic.
format article
author Daniel J. McGrail
Curtis Chun-Jen Lin
Jeannine Garnett
Qingxin Liu
Wei Mo
Hui Dai
Yiling Lu
Qinghua Yu
Zhenlin Ju
Jun Yin
Christopher P. Vellano
Bryan Hennessy
Gordon B. Mills
Shiaw-Yih Lin
author_facet Daniel J. McGrail
Curtis Chun-Jen Lin
Jeannine Garnett
Qingxin Liu
Wei Mo
Hui Dai
Yiling Lu
Qinghua Yu
Zhenlin Ju
Jun Yin
Christopher P. Vellano
Bryan Hennessy
Gordon B. Mills
Shiaw-Yih Lin
author_sort Daniel J. McGrail
title Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
title_short Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
title_full Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
title_fullStr Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
title_full_unstemmed Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
title_sort improved prediction of parp inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/b2d7262023a5464f9e1788ca4d9c8cbf
work_keys_str_mv AT danieljmcgrail improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT curtischunjenlin improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT jeanninegarnett improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT qingxinliu improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT weimo improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT huidai improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT yilinglu improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT qinghuayu improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT zhenlinju improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT junyin improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT christopherpvellano improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT bryanhennessy improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT gordonbmills improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
AT shiawyihlin improvedpredictionofparpinhibitorresponseandidentificationofsynergizingagentsthroughuseofanovelgeneexpressionsignaturegenerationalgorithm
_version_ 1718395420743303168